Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.

Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR.

Am J Psychiatry. 2006 Jul;163(7):1199-201.

PMID:
16816224
2.

Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.

Sachs G, Bowden C, Calabrese JR, Ketter T, Thompson T, White R, Bentley B.

Bipolar Disord. 2006 Apr;8(2):175-81.

PMID:
16542188
3.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.

Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J; Lamictal 606 Study Group.

Arch Gen Psychiatry. 2003 Apr;60(4):392-400. Erratum in: Arch Gen Psychiatry. 2004 Jul;61(7):680.

PMID:
12695317
4.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
5.
6.
7.

Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.

Frye MA, Yatham L, Ketter TA, Goldberg J, Suppes T, Calabrese JR, Bowden CL, Bourne E, Bahn RS, Adams B.

Acta Psychiatr Scand. 2009 Jul;120(1):10-3. doi: 10.1111/j.1600-0447.2008.01343.x. Epub 2009 Jan 31.

PMID:
19183414
8.

Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.

Kemp DE, De Hert M, Rahman Z, Fyans P, Eudicone JM, Marler SV, Baker RA, Carlson BX.

J Affect Disord. 2013 May 15;148(1):84-91. doi: 10.1016/j.jad.2012.11.054. Epub 2012 Dec 20.

PMID:
23261129
9.

Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.

Calabrese JR, Goldberg JF, Ketter TA, Suppes T, Frye M, White R, DeVeaugh-Geiss A, Thompson TR.

Biol Psychiatry. 2006 Jun 1;59(11):1061-4.

PMID:
16769295
10.

A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.

Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET.

J Clin Psychiatry. 2000 Nov;61(11):841-50.

PMID:
11105737
11.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
12.

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD.

J Clin Psychiatry. 1999 Feb;60(2):79-88.

PMID:
10084633
13.

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R.

J Clin Psychiatry. 2004 Mar;65(3):432-41.

PMID:
15096085
14.

A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.

McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J.

J Clin Psychiatry. 2004 Feb;65(2):204-10.

PMID:
15003074
15.

Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.

Frye MA, Yatham LN, Calabrese JR, Bowden CL, Ketter TA, Suppes T, Adams BE, Thompson TR.

J Clin Psychiatry. 2006 Nov;67(11):1721-8.

PMID:
17196051
16.

Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.

Goldberg JF, Calabrese JR, Saville BR, Frye MA, Ketter TA, Suppes T, Post RM, Goodwin FK.

J Clin Psychiatry. 2009 Sep;70(9):1273-80. doi: 10.4088/JCP.08m04381. Epub 2009 Aug 11.

PMID:
19689918
17.

Safety of available agents used to treat bipolar disorder: focus on weight gain.

Nemeroff CB.

J Clin Psychiatry. 2003 May;64(5):532-9. Review.

PMID:
12755655
18.
19.

Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

van der Loos ML, Mulder P, Hartong EG, Blom MB, Vergouwen AC, van Noorden MS, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

Bipolar Disord. 2011 Feb;13(1):111-7. doi: 10.1111/j.1399-5618.2011.00887.x.

PMID:
21320258
20.

Bipolar rapid cycling: focus on depression as its hallmark.

Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ.

J Clin Psychiatry. 2001;62 Suppl 14:34-41. Review.

Supplemental Content

Support Center